Cancerwise

Cancer treatment is increasingly tailored to the unique genetic makeup of each patient’s tumor. At the 2026 American Society for Clinical Oncology (ASCO) Annual Meeting, UT MD Anderson clinicians and researchers are showcasing breakthrough therapies targeting specific mutations and/or rare subsets of cancer, offering new hope for patients with historically hard-to-treat cancers.

Sharing our researchers’ findings and ideas at conferences...